TargetMol

Relamorelin

Product Code:
 
TAR-T34281
Product Group:
 
Peptides
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T34281-100mg100mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T34281-500mg500mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Relamorelin(BIM28131, RM131) is a pentapeptide and auxin-released peptide analog with improved potency and pharmacokinetics. It is a centrally penetrant, selective agonist of the ghrelin/growth hormone secretagogue receptor (GHSR) potentially useful for the treatment of diabetic gastroparesis, chronic idiopathic constipation, and anorexia nervosa.
CAS:
661472-41-9
Molecular Weight:
790.98
Purity:
0.98
SMILES:
NC(=O)C1(CCNCC1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](Cc1csc2ccccc12)NC(=O)C1CCNCC1

References

Acosta A, Camilleri M, Busciglio I, Boldingh A, Nelson AD, Burton D. Short-Term Effects of Relamorelin on Descending Colon Motility in Chronic Constipation: A Randomized, Controlled Trial. Dig Dis Sci. 2015 Oct 14. [Epub ahead of print] PubMed PMID: 26467700. Camilleri M. Novel Diet, Drugs and Gastric Interventions for Gastroparesis. Clin Gastroenterol Hepatol. 2016 Jan 4. pii: S1542-3565(15)01724-3. doi: 10.1016/j.cgh.2015.12.033. [Epub ahead of print] Review. PubMed PMID: 26762845. Bassotti G. Relamorelin to Treat Constipation: "Pusher" or Pushover? Dig Dis Sci. 2015 Oct 24. [Epub ahead of print] PubMed PMID: 26500115. Sanger GJ, Furness JB. Ghrelin and motilin receptors as drug targets for gastrointestinal disorders. Nat Rev Gastroenterol Hepatol. 2016 Jan;13(1):38-48. doi: 10.1038/nrgastro.2015.163. Epub 2015 Sep 22. Review. PubMed PMID: 26392067.